Trade Summary

4 days ago, Canton Barry, serving as 10% owner at Ginkgo Bioworks Holdings, Inc. (DNA), sold 124,727 shares at $6.43 per share, for a total transaction value of $802,494.00. Following this transaction, Canton Barry now holds 436,422 shares of DNA.

This sale represents a 22.00% decrease in Canton Barry's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, April 10, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 13, 2026, 3 days after the trade was made.

Ginkgo Bioworks Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.